Author:
Azarova I. E.,Klyosova E. Yu.,Kolomoets I. I.,Azarova V. A.,Ivakin V. E.,Konoplya A. I.,Polonikov A. V.
Reference34 articles.
1. Global Report on Diabetes: Executive Summary, World Health Organization, no. WHO/NMH/NVI/16.3, 2016.
2. Cho, N., Shaw, J.E., Karuranga, S., et al., IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045, Diabetes Res. Clin. Pract., 2018, no. 138, pp. 271—281. https://doi.org/10.1016/j.diabres.2018.02.023
3. Dedov, I.I., Shestakova, M.V., Vikulova, O.K., et al., Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, status 2017, Diabetes Mellitus, 2018, vol. 21, no. 3, pp. 144—159. https://doi.org/10.14341/DM9686
4. Shestakova, M.V. and Sukhareva, O.Yu., Diagnosis and the choice of treatment for type 2 diabetes mellitus, Klin. Farmakol. Ter., 2018, vol. 27, no. 2, pp. 1—7.
5. Dedov, I.I., Smirnova, O.M., and Kononenko, I.V., Significance of the results of genome-wide association studies for primary prevention of type 2 diabetes mellitus and its complications: a personalized approach, Sakh. Diabet, 2014, no. 2, pp. 10—19.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献